Zomig and ill-defined disorder Patient Reports February 11, 2012
Zomig Side Effects Report #5233944-1
Zomig side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 01, 2007. Female patient, 67 years of age, weighting 147.9 lb, was diagnosed with migraine
and was treated with Zomig. After drug was administered, patient experienced the following side effects: autonomic nervous system imbalance, disorientation, dizziness
, hypoaesthesia, ill-defined disorder, loss of consciousness, rebound effect. Zomig dosage: unknown. Patient recovered.Zomig Side Effects Report #5337096-9
Zomig side effect was reported by a Consumer or non-health professional from UNITED STATES on May 22, 2007. Female patient, 67 years of age, weighting 147.9 lb, was diagnosed with migraine
and was treated with Zomig. After drug was administered, patient experienced the following side effects: autonomic nervous system imbalance, disorientation, dizziness
, hypoaesthesia, ill-defined disorder, loss of consciousness, rebound effect. Zomig dosage: unknown. Patient recovered.Zomig Side Effects Report #4735257-0
Zomig side effect was reported by a Consumer or non-health professional from UNITED STATES on July 29, 2005. Female patient, 52 years of age, was diagnosed with migraine
and was treated with Zomig. After drug was administered, patient experienced the following side effects: blood glucose decreased, ill-defined disorder. Zomig dosage: unknown. Patient recovered.Zomig Side Effects Report #5718277-9
Zomig side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 12, 2007. Female patient, 46 years of age, weighting 119.9 lb, was diagnosed with migraine
and was treated with Zomig. After drug was administered, patient experienced the following side effects: dizziness
, feeling abnormal, ill-defined disorder, vomiting. Zomig dosage: unknown. Patient recovered.Zomig Side Effects Report #5615444-X
Zomig side effect was reported by a Health Professional from SPAIN on Jan 31, 2008. Female patient, 36 years of age, was diagnosed with migraine
, antibiotic prophylaxis, ill-defined disorder, nausea
, pain
and was treated with Zomig. After drug was administered, patient experienced the following side effects: chest pain
, dyspnoea, ill-defined disorder, respiratory failure. Zomig dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, ZANTAC, GENTAMICIN, METOCLOPRAMIDE, ENANTYUM. Patient was hospitalized. Patient recovered.
Zomig and ill-defined disorder 